|
STAMBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.932000E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.541200E-01 |
| Normal-vs-Stage2 |
3.499600E-01 |
| Normal-vs-Stage3 |
4.017700E-02 |
| Normal-vs-Stage4 |
3.250300E-02 |
| Stage1-vs-Stage2 |
5.995600E-01 |
| Stage1-vs-Stage3 |
1.456370E-01 |
| Stage1-vs-Stage4 |
1.013380E-01 |
| Stage2-vs-Stage3 |
5.729400E-01 |
| Stage2-vs-Stage4 |
5.026600E-01 |
| Stage3-vs-Stage4 |
9.287600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.664400E-02 |
| Normal-vs-AfricanAmerican |
2.049300E-04 |
| Normal-vs-Asian |
2.546000E-01 |
| Caucasian-vs-AfricanAmerican |
4.962200E-03 |
| Caucasian-vs-Asian |
1.900240E-01 |
| AfricanAmerican-vs-Asian |
7.974000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.839700E-03 |
| Normal-vs-Female |
5.267200E-01 |
| Male-vs-Female |
1.176240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.334400E-02 |
| Normal-vs-Age(41-60Yrs) |
2.130200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.452100E-02 |
| Normal-vs-Age(81-100Yrs) |
2.694800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.073850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.020200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.390800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.529400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.083000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.830200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.599400E-01 |
| Normal-vs-Grade 2 |
4.583000E-01 |
| Normal-vs-Grade 3 |
1.012060E-02 |
| Normal-vs-Grade 4 |
1.227220E-01 |
| Grade 1-vs-Grade 2 |
7.141600E-01 |
| Grade 1-vs-Grade 3 |
3.284600E-01 |
| Grade 1-vs-Grade 4 |
2.579600E-01 |
| Grade 2-vs-Grade 3 |
8.509900E-02 |
| Grade 2-vs-Grade 4 |
2.678800E-01 |
| Grade 3-vs-Grade 4 |
9.408600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.788200E-01 |
| Normal-vs-ccB subtype |
4.134300E-02 |
| ccA subtype-vs-ccB subtype |
4.844800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.416200E-01 |
| Normal-vs-N1 |
9.810200E-01 |
| N0-vs-N1 |
6.873000E-01 |
|
|
